-
Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?
Vedder, D., Heslinga, M., Wijbrandts, C. A., Nurmohamed, M. T. & Gerritsen, M., 1 Sept 2023, In: Clinical and experimental rheumatology. 41, 9, p. 1762-1767 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Østergaard, M., van Vollenhoven, R. F., Rudin, A., Hetland, M. L., Heiberg, M. S., Nordström, D. C., Nurmohamed, M. T., Gudbjornsson, B., Ørnbjerg, L. M., Bøyesen, P., Lend, K., Hørslev-Petersen, K., Uhlig, T., Sokka, T., Grondal, G., Krabbe, S., Lindqvist, J., Gjertsson, I., Glinatsi, D., Kapetanovic, M. C., & 25 others, 2023, (E-pub ahead of print) In: Annals of the rheumatic diseases.Research output: Contribution to journal › Article › Academic › peer-review
-
The heartbeat of gout: The relationship between gout and cardiovascular disease and its management
Vedder, D., 3 Nov 2022, Alblasserdam: Ridderprint. 216 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications
